Key Competitors - Systemic Scleroderma Treatment Industry

May, 2023 - by CMI

Key Competitors - Systemic Scleroderma Treatment Industry

Scleroderma, also known as sclerosis is a rare, chronic disorder involving overproduction and accumulation of collagen in the tissue of the body. Scleroderma majorly affects skin but is not limited to the skin and also affects several major internal organs such as kidney, lungs, heart and others. Scleroderma can become life-threatening if untreated at the right time.

As of 2021, the Global Systemic Scleroderma Treatment Market is estimated to be valued at U.S.$ 1,520.1 Million and is expected to exhibit a CAGR of 4.2% during the years (2021-2028)

Leading Companies in the Systemic Scleroderma Treatment Industry: 

1) Hoffman-La Roche AG

Hoffman-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company known for operating worldwide. Roche is the fifth largest pharmaceutical company in the world by revenue, and also the leading provider of cancer treatments globally. The company was founded in the year 1896, and the headquarters are located in Basel, Switzerland. The company was founded by Fritz Hoffmann-La Roche.

In March 2021, Roche announced its plans of acquiring GenMark Diagnostics for U.S. $ 1.8 Billion. In September 2021, the company announced it would acquire German Biotech Group, TIB Molbiol.

2) Pfizer Inc.

Pfizer Inc. is a pharmaceutical and biotechnology company based in America. It was founded in the year 1849. Pfizer manufactures and produces vaccines and medicine related to oncology, neurology, cardiology, and immunology. The corporation has produced various products that yield more than US$1 billion in annual revenue.

The company ranked 64th on the Fortune 500 and 49th on the Forbes Global 2000. The headquarters are located in New York City, U.S. and the products manufactured are sold worldwide. The company was founded by Charles Pfizer and Charles F. Erhart.

As of January 2023, Pfizer Inc. and Abzena have entered into an agreement under which Pfizer will be acquiring Abzena’s manufacturing facility in Sanford, North Carolina

3) Eli Lilly and Company

Eli Lilly and Company is an American pharmaceutical company. The products manufactured are sold in approximately 120 countries. The company is known for its clinical depression drugs Prozac, Cymbalta, and its antipsychotic medication Zyprexa. The company was founded in the year 1876, and the headquarters are located in Indianapolis, Indiana. The company was founded by Eli Lily.

In October 2022, Eli Lilly completed the acquisition of Akouos Inc. a biotechnology company focusing on restoring and preserving hearing

4) Bayer AG

Bayer AG is a pharmaceutical and biotechnology company situated in Germany. It is one of the largest Pharma Company in the world. The headquarters are located in Leverkusen, North Rhine- Westphalia, Germany. The company was founded in the year 1863 by Friedrich Bayer. Bayer AG’s first ever manufactured product was acetylsalicylic acid. Since then it has manufactured many more products like heroin, phenobarbital, polyurethanes, however stopped producing them. The area of business is mainly healthcare products for consumers, agricultural chemicals.

In June 2021, Bayer AG completed the acquisition of Noria Therapeutics Inc. and PSMA Therapeutics Inc.

5) Sanofi S.A.

Sanofi S.A. is a multinational pharmaceutical company that engages in the research and development, of pharmacological products, in the prescription market. The firm cover therapeutic areas like Cardiovascular, central nervous system, diabetes, internal medicine. The company was founded in 973 and the headquarters are located in Paris, France. Products manufactured include Medications, Genetic drugs, Vaccines, Animal Health, etc.

In December, 2022 Sanofi expanded its collaboration with Innate Pharma, with Sanofi licensing a natural killer (NK) cell nagger program targeting B7H3 from Innate’s ANKET platform.

6) AstraZeneca Plc.

AstraZeneca Plc. Is a multinational pharmaceutical and biotechnology company. The company is known for manufacturing products for major diseases like Oncology, Cardiovascular, Infection, Respiratory and Inflammation. Apart from that, it has also been a part of developing the Oxford-AstraZeneca Covid-19 vaccine. The company was founded in 1999 and the headquarters are located in Cambridge, England, UK.

In July of 2021 AstraZeneca completed the acquisition of Alexion Pharmaceuticals, Inc. In January of 2023, AstraZeneca also announced its plans to acquired CinCor a biopharmaceutical company based in the U.S.

7) Amgen Inc.

Amgen Inc. (Applied Molecular Genetics Inc.) is a biopharmaceutical company based in America. It is one of the world’s largest biotechnology company. The company was founded in the year 1980 on the 8th of April. The headquarters are located in Thousand Oaks, California, U.S. The company sells its products worldwide and some of them include Aimovig, Enbrel, Prolia, Xgeva, Nplate etc. The company was founded by William K.

In August 2022, Amgen agreed to acquire ChemoCentryx, a company that makes Tavneos, a drug treatment for rare diseases. Amgen acquired the company for US$ 3.7 Billion.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.